• Acrivon Therapeutics (NASDAQ:ACRV) Price Target Cut to $27.00 by Analysts at BMO Capital Markets

    Source: Buzz FX / 14 Nov 2024 12:31:18   America/New_York


    Acrivon Therapeutics (NASDAQ:ACRV) Price Target Cut to $27.00 by Analysts at BMO Capital Markets Written by MarketBeat November 14, 2024 Share Link copied to clipboard. Acrivon Therapeutics ( NASDAQ:ACRV - Get Free Report ) had its target p
    Read more...
Share on,